Thus, by corroborating this fact with data that establish CABP29K as a typical mesothelioma marker, which is an aggressively malignant cancer, the conclusion is that diagnostic and therapeutic strategies may seriously interfere with the questionable expression of calretinin in lung tumors [58]. The gene discussed is CALB2; the disease is cancer.